JNJ - Johnson & Johnson
Close
165.86
1.630 0.983%
Share volume: 7,488,754
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$164.23
1.63
0.99%
Fundamental analysis
71%
Profitability
81%
Dept financing
36%
Liquidity
70%
Performance
70%
Performance
5 Days
1.82%
1 Month
3.59%
3 Months
15.03%
6 Months
4.28%
1 Year
4.51%
2 Year
8.37%
Key data
Stock price
$165.86
DAY RANGE
$163.81 - $165.98
52 WEEK RANGE
$140.50 - $165.98
52 WEEK CHANGE
$0.07
DIVIDEND
$1.24
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
10/15/2024
Company detail
CEO: Alex Gorsky
Region: US
Website: https://www.jnj.com/
Employees: 152,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.jnj.com/
Employees: 152,700
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Recent news